Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkin Lymphoma, B-cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT04342117
What this trial is testing

Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL

Who this might be right for
Lymphoma, Small LymphocyticLymphomaLymphoma, Non-Hodgkin+2 more
SecuraBio 2
Testing effectiveness (Phase 2)Study completedNCT00764517
What this trial is testing

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Indolent Adult Non-Hodgkin Lymphoma+1 more
OHSU Knight Cancer Institute 57
Testing effectiveness (Phase 2)Study completedNCT00612183
What this trial is testing

Clinical Study on SyB L-0501 in Patients With Indolent B-cell Non-Hodgkin's Lymphoma or Mantle Cell Lymphoma

Who this might be right for
Non-Hodgkin's LymphomaMantle Cell Lymphoma
SymBio Pharmaceuticals 56
Not applicableLooking for participantsNCT05255354
What this trial is testing

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

Who this might be right for
Follicular LymphomaDiffuse Large B Cell LymphomaMantle Cell Lymphoma
Adaptive Biotechnologies 300
Testing effectiveness (Phase 2)Study completedNCT03677141
What this trial is testing

A Phase Ib/II Study Investigating the Safety, Tolerability, Pharmacokinetics, and Efficacy of Mosunetuzumab (BTCT4465A) in Combination With CHOP or CHP-Polatuzumab Vedotin in Participants With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non-Hodgkin Lymphoma
Hoffmann-La Roche 117
Testing effectiveness (Phase 2)Study completedNCT00059995
What this trial is testing

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Not applicableNot Yet RecruitingNCT07711327
What this trial is testing

Atrial Fibrillation Among Patients With Hematologic Malignancies on Tyrosine Kinase Inhibitor Therapy

Who this might be right for
Atrial Fibrillation (AF)Chronic Lymphocytic LeukemiaWaldenstrom Macroglobulinemia+2 more
Tina Baykaner 500
Testing effectiveness (Phase 2)Ended earlyNCT01549886
What this trial is testing

Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Spectrum Pharmaceuticals, Inc 5
Not applicableUnknownNCT04870853
What this trial is testing

Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy

Who this might be right for
Recurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+7 more
M.D. Anderson Cancer Center 150
Large-scale testing (Phase 3)Ended earlyNCT00169169
What this trial is testing

Efficacy Study of Rituximab After ASCT in High-Risk Diffuse Large B-Cell Lymphoma

Who this might be right for
CD20-Positive Large B-Cell Lymphoma
Lymphoma Study Association 430
Testing effectiveness (Phase 2)Study completedNCT00436280
What this trial is testing

Chemotherapy for Participants With Lymphoma

Who this might be right for
Lymphoma, Large Cell, Diffuse
Eli Lilly and Company 68
Early research (Phase 1)Ended earlyNCT02454270
What this trial is testing

A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+2 more
Janssen Research & Development, LLC 59
Testing effectiveness (Phase 2)Looking for participantsNCT06014073
What this trial is testing

TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL

Who this might be right for
Non Hodgkin's Lymphoma
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Not applicableStudy completedNCT02520895
What this trial is testing

Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia

Who this might be right for
LYMPHOMA
Hospices Civils de Lyon 98
Early research (Phase 1)Study completedNCT03072771
What this trial is testing

Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B Cell Lymphoma
Washington University School of Medicine 14
Testing effectiveness (Phase 2)Study completedNCT00142181
What this trial is testing

Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia

Who this might be right for
Lymphoplasmacytic LymphomaWaldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 27
Testing effectiveness (Phase 2)Study completedNCT00028730
What this trial is testing

Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+1 more
Memorial Sloan Kettering Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT01980628
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma

Who this might be right for
Marginal Zone LymphomaB-cell Lymphoma
Pharmacyclics LLC. 63
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Next Page